Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophreniaIzzat T Raheem, Michael J Breslin, Christine Fandozzi, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Neuron|March 31, 2005
Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortexPhilip E Brandish, Ming Su, Daniel J Holder, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2015
Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitorsChristopher D Cox, Eric D Hostetler, Broc A Flores, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2010
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the ratPaul J Coleman, John D Schreier, Anthony J Roecker, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2016
Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitorsThomas J Greshock, John M Sanders, Robert E Drolet, et al.
Journal of Neurogenetics|November 19, 2011
Pharmacological validation of candidate causal sleep genes identified in an N2 crossJoseph I Brunner, Anthony L Gotter, Joshua Millstein, et al.
Plos One|April 11, 2009
Uncovering the genetic landscape for multiple sleep-wake traitsChristopher J Winrow, Deanna L Williams, Andrew Kasarskis, et al.
Pageof 13